Muscle Mass Loss With GLP-1 Therapy: Clinical Relevance and Mitigation

Cited in blog · Lancet Diabetes & Endocrinology. · 2025

Prado CM et al. (2025). *Muscle Mass Loss With GLP-1 Therapy: Clinical Relevance and Mitigation*. Lancet Diabetes & Endocrinology.

Authors

Prado CM et al.

Research lens

Prado CM et al. (2025). *Muscle Mass Loss With GLP-1 Therapy: Clinical Relevance and Mitigation*. Lancet Diabetes & Endocrinology.

  • blog
  • greek-yogurt-startups-ride-america-s-protein-obsession-2026-07-07